Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Table of Contents

PreviousNext

September 01 1999; volume 48 issue 9

  • You have accessRestricted Access
    Onset of type 1 diabetes: a dynamical instability.
    B Freiesleben De Blasio, P Bak, F Pociot, A E Karlsen and J Nerup
    Diabetes 1999 Sep; 48 (9): 1677-1685. https://doi.org/10.2337/diabetes.48.9.1677
    Add to Selected Citations
  • You have accessRestricted Access
    Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion.
    S Daniel, M Noda, S G Straub and G W Sharp
    Diabetes 1999 Sep; 48 (9): 1686-1690. https://doi.org/10.2337/diabetes.48.9.1686
    Add to Selected Citations
  • You have accessRestricted Access
    Long-term regulation of lipolysis and hormone-sensitive lipase by insulin and glucose.
    L M Botion and A Green
    Diabetes 1999 Sep; 48 (9): 1691-1697. https://doi.org/10.2337/diabetes.48.9.1691
    Add to Selected Citations
  • You have accessRestricted Access
    Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia.
    B Mahalingam, A Cuesta-Munoz, E A Davis, F M Matschinsky, R W Harrison and I T Weber
    Diabetes 1999 Sep; 48 (9): 1698-1705. https://doi.org/10.2337/diabetes.48.9.1698
    Add to Selected Citations
  • You have accessRestricted Access
    Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.
    M S Haque, Y Minokoshi, M Hamai, M Iwai, M Horiuchi and T Shimazu
    Diabetes 1999 Sep; 48 (9): 1706-1712. https://doi.org/10.2337/diabetes.48.9.1706
    Add to Selected Citations
  • You have accessRestricted Access
    Neonatal porcine islet cells induce human CD4+, but not CD8+, lymphocyte proliferation and resist cell-mediated cytolytic injury in vitro.
    A G Murray, R C Nelson, G R Rayat, J F Elliott and G S Korbutt
    Diabetes 1999 Sep; 48 (9): 1713-1719. https://doi.org/10.2337/diabetes.48.9.1713
    Add to Selected Citations
  • You have accessRestricted Access
    Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.
    I Bergerot, G A Arreaza, M J Cameron, M D Burdick, R M Strieter, S W Chensue, S Chakrabarti and T L Delovitch
    Diabetes 1999 Sep; 48 (9): 1720-1729. https://doi.org/10.2337/diabetes.48.9.1720
    Add to Selected Citations
  • You have accessRestricted Access
    Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro.
    N Giannoukakis, W A Rudert, S C Ghivizzani, A Gambotto, C Ricordi, M Trucco and P D Robbins
    Diabetes 1999 Sep; 48 (9): 1730-1736. https://doi.org/10.2337/diabetes.48.9.1730
    Add to Selected Citations
  • You have accessRestricted Access
    Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation.
    R P Robertson, D E Sutherland and K J Lanz
    Diabetes 1999 Sep; 48 (9): 1737-1740. https://doi.org/10.2337/diabetes.48.9.1737
    Add to Selected Citations
  • You have accessRestricted Access
    Corticotropin-releasing factor modulation of Ca2+ influx in rat pancreatic beta-cells.
    T Kanno, S Suga, K Nakano, N Kamimura and M Wakui
    Diabetes 1999 Sep; 48 (9): 1741-1746. https://doi.org/10.2337/diabetes.48.9.1741
    Add to Selected Citations
  • You have accessRestricted Access
    Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets.
    Y Q Liu, K Tornheim and J L Leahy
    Diabetes 1999 Sep; 48 (9): 1747-1753. https://doi.org/10.2337/diabetes.48.9.1747
    Add to Selected Citations
  • You have accessRestricted Access
    A defect late in stimulus-secretion coupling impairs insulin secretion in Goto-Kakizaki diabetic rats.
    S A Metz, M Meredith, J Vadakekalam, M E Rabaglia and A Kowluru
    Diabetes 1999 Sep; 48 (9): 1754-1762. https://doi.org/10.2337/diabetes.48.9.1754
    Add to Selected Citations
  • You have accessRestricted Access
    Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms.
    X J Yang, L M Kow, T Funabashi and C V Mobbs
    Diabetes 1999 Sep; 48 (9): 1763-1772. https://doi.org/10.2337/diabetes.48.9.1763
    Add to Selected Citations
  • You have accessRestricted Access
    Expression of alpha-1 proteinase inhibitor in human islet microvascular endothelial cells.
    J Lou, F Triponez, J Oberholzer, H Wang, D Yu, L Buhler, N Cretin, G Mentha, C B Wollheim and P Morel
    Diabetes 1999 Sep; 48 (9): 1773-1778. https://doi.org/10.2337/diabetes.48.9.1773
    Add to Selected Citations
  • You have accessRestricted Access
    Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes.
    M P Hermans, J C Levy, R J Morris and R C Turner
    Diabetes 1999 Sep; 48 (9): 1779-1786. https://doi.org/10.2337/diabetes.48.9.1779
    Add to Selected Citations
  • You have accessRestricted Access
    Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion.
    N Satoh, Y Ogawa, G Katsuura, Y Numata, T Tsuji, M Hayase, K Ebihara, H Masuzaki, K Hosoda, Y Yoshimasa and K Nakao
    Diabetes 1999 Sep; 48 (9): 1787-1793. https://doi.org/10.2337/diabetes.48.9.1787
    Add to Selected Citations
  • You have accessRestricted Access
    T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
    A Oku, K Ueta, K Arakawa, T Ishihara, M Nawano, Y Kuronuma, M Matsumoto, A Saito, K Tsujihara, M Anai, T Asano, Y Kanai and H Endou
    Diabetes 1999 Sep; 48 (9): 1794-1800. https://doi.org/10.2337/diabetes.48.9.1794
    Add to Selected Citations
  • You have accessRestricted Access
    Altered hypothalamic function in response to glucose ingestion in obese humans.
    M Matsuda, Y Liu, S Mahankali, Y Pu, A Mahankali, J Wang, R A DeFronzo, P T Fox and J H Gao
    Diabetes 1999 Sep; 48 (9): 1801-1806. https://doi.org/10.2337/diabetes.48.9.1801
    Add to Selected Citations
  • You have accessRestricted Access
    Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes.
    J E Friedman, T Ishizuka, J Shao, L Huston, T Highman and P Catalano
    Diabetes 1999 Sep; 48 (9): 1807-1814. https://doi.org/10.2337/diabetes.48.9.1807
    Add to Selected Citations
  • You have accessRestricted Access
    Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans.
    S J Bradley, B A Kingwell and G K McConell
    Diabetes 1999 Sep; 48 (9): 1815-1821. https://doi.org/10.2337/diabetes.48.9.1815
    Add to Selected Citations
  • You have accessRestricted Access
    Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.
    Y Ogawa, H Masuzaki, K Hosoda, M Aizawa-Abe, J Suga, M Suda, K Ebihara, H Iwai, N Matsuoka, N Satoh, H Odaka, H Kasuga, Y Fujisawa, G Inoue, H Nishimura, Y Yoshimasa and K Nakao
    Diabetes 1999 Sep; 48 (9): 1822-1829. https://doi.org/10.2337/diabetes.48.9.1822
    Add to Selected Citations
  • You have accessRestricted Access
    Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
    Y Tang, H Osawa, H Onuma, T Nishimiya, M Ochi and H Makino
    Diabetes 1999 Sep; 48 (9): 1830-1835. https://doi.org/10.2337/diabetes.48.9.1830
    Add to Selected Citations
  • You have accessRestricted Access
    Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    A T Santomauro, G Boden, M E Silva, D M Rocha, R F Santos, M J Ursich, P G Strassmann and B L Wajchenberg
    Diabetes 1999 Sep; 48 (9): 1836-1841. https://doi.org/10.2337/diabetes.48.9.1836
    Add to Selected Citations
  • You have accessRestricted Access
    Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
    R Shibayama, N Araki, R Nagai and S Horiuchi
    Diabetes 1999 Sep; 48 (9): 1842-1849. https://doi.org/10.2337/diabetes.48.9.1842
    Add to Selected Citations
  • You have accessRestricted Access
    Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.
    S K Jain and R McVie
    Diabetes 1999 Sep; 48 (9): 1850-1855. https://doi.org/10.2337/diabetes.48.9.1850
    Add to Selected Citations
  • You have accessRestricted Access
    Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    A E Caballero, S Arora, R Saouaf, S C Lim, P Smakowski, J Y Park, G L King, F W LoGerfo, E S Horton and A Veves
    Diabetes 1999 Sep; 48 (9): 1856-1862. https://doi.org/10.2337/diabetes.48.9.1856
    Add to Selected Citations
  • You have accessRestricted Access
    A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor.
    B D Mitchell, S A Cole, A G Comuzzie, L Almasy, J Blangero, J W MacCluer and J E Hixson
    Diabetes 1999 Sep; 48 (9): 1863-1867. https://doi.org/10.2337/diabetes.48.9.1863
    Add to Selected Citations
  • You have accessRestricted Access
    Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study.
    H H Lei, J Coresh, A R Shuldiner, E Boerwinkle and F L Brancati
    Diabetes 1999 Sep; 48 (9): 1868-1872. https://doi.org/10.2337/diabetes.48.9.1868
    Add to Selected Citations
  • You have accessRestricted Access
    Isolation, characterization, and chromosomal localization of the human ENSA gene that encodes alpha-endosulfine, a regulator of beta-cell K(ATP) channels.
    L Héron, A Virsolvy, F Apiou, A Le Cam and D Bataille
    Diabetes 1999 Sep; 48 (9): 1873-1876. https://doi.org/10.2337/diabetes.48.9.1873
    Add to Selected Citations
  • You have accessRestricted Access
    Human insulin receptor substrate-2: gene organization and promoter characterization.
    L Vassen, W Wegrzyn and L Klein-Hitpass
    Diabetes 1999 Sep; 48 (9): 1877-1880. https://doi.org/10.2337/diabetes.48.9.1877
    Add to Selected Citations
  • You have accessRestricted Access
    A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance.
    A Pizzuti, L Frittitta, A Argiolas, R Baratta, I D Goldfine, M Bozzali, T Ercolino, G Scarlato, L Iacoviello, R Vigneri, V Tassi and V Trischitta
    Diabetes 1999 Sep; 48 (9): 1881-1884. https://doi.org/10.2337/diabetes.48.9.1881
    Add to Selected Citations
  • You have accessRestricted Access
    Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence.
    J E Ayala, R S Streeper, J S Desgrosellier, S K Durham, A Suwanichkul, C A Svitek, J K Goldman, F G Barr, D R Powell and R M O'Brien
    Diabetes 1999 Sep; 48 (9): 1885-1889. https://doi.org/10.2337/diabetes.48.9.1885
    Add to Selected Citations
  • You have accessRestricted Access
    Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis.
    W K Chung, A Luke, R S Cooper, C Rotini, A Vidal-Puig, M Rosenbaum, M Chua, G Solanes, M Zheng, L Zhao, C LeDuc, A Eisberg, F Chu, E Murphy, M Schreier, L Aronne, S Caprio, B Kahle, D Gordon, S M Leal, R Goldsmith, A L Andreu, C Bruno, S DiMauro and R L Leibel
    Diabetes 1999 Sep; 48 (9): 1890-1895. https://doi.org/10.2337/diabetes.48.9.1890
    Add to Selected Citations
Back to top
PreviousNext

In this Issue

September 1999, 48(9)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
  • Most Read
  • Most Cited
Loading
  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
  • Latent Autoimmune Diabetes in Adults
  • Poverty and Obesity in the U.S.
  • The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
  • A Polymorphism in the Glucocorticoid Receptor Gene, Which Decreases Sensitivity to Glucocorticoids In Vivo, Is Associated With Low Insulin and Cholesterol Levels
More...

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.